Supporting inflammatory bowel disease research, patient advocacy, and a future free from Crohn’s disease and ulcerative colitis.
We believe that improving patient care goes beyond providing high-quality infusion therapy. It also means supporting organizations that advance medical research, raise awareness, and make a meaningful difference in the lives of patients and families.
On November 9, 2026, Thrivewell Infusion was proud to sponsor the Crohn’s & Colitis Foundation’s 59th Annual Gala, Broadway’s Got Guts!, held at the iconic Edison Ballroom in New York City. The memorable evening brought together healthcare professionals, patients, caregivers, advocates, and community supporters for inspiring stories, Broadway performances, and a shared commitment to improving the lives of those affected by Crohn’s disease and ulcerative colitis, collectively known as inflammatory bowel disease (IBD).

For nearly six decades, the Crohn’s & Colitis Foundation has been dedicated to advancing research, improving access to care, and supporting individuals living with IBD. Since its founding in 1967, the Foundation has invested more than $500 million in research aimed at understanding the causes of Crohn’s disease and ulcerative colitis, developing improved treatments, and working toward cures. Beyond funding research, the organization provides educational resources, advocacy initiatives, and patient support programs that help individuals navigate the challenges of living with chronic digestive diseases.
This year’s Broadway’s Got Guts! Gala was another incredible example of that mission in action, with supporters helping raise nearly $865,000 toward advancing research, patient education, and community support programs.
A special highlight of the evening was the celebration of 25 years of Camp Oasis NY, a life- changing program designed for children and teens living with Crohn’s disease and ulcerative colitis. Operated by the Crohn’s & Colitis Foundation, Camp Oasis provides a safe, supportive summer camp experience where young people with IBD can participate in traditional camp activities while connecting with peers who understand the challenges of managing a chronic condition. For many children, living with IBD can mean navigating unpredictable symptoms, treatment schedules, and feelings of isolation. Camp Oasis offers an opportunity to build lasting friendships, develop confidence, and experience the joy of simply being a kid. Celebrating this milestone was a meaningful reminder that supporting patients means addressing not only their medical needs but also their emotional and social well-being.
The evening also celebrated two outstanding healthcare leaders whose contributions have helped advance inflammatory bowel disease research and patient care. Dr. Jean-Frederic Colombel received the inaugural Scientific Leadership Award, recognizing his contributions to IBD research and the advancement of gastroenterology. Isabel Roitman, MBA, NP-BC, was honored with the Rosenthal Humanitarian Award, becoming the first nurse to receive this recognition. Her achievement highlighted the essential role nurses play in delivering compassionate, patient-centered healthcare and supporting individuals living with chronic conditions.
These honorees represent the dedication, innovation, and compassion that continue to shape the future of IBD treatment and care.
For individuals living with Crohn’s disease and ulcerative colitis, managing a chronic condition often requires ongoing medical care and long-term treatment. Depending on a patient’s diagnosis and treatment plan, infusion therapy may play an important role in managing inflammation, controlling symptoms, and helping patients maintain their quality of life.
We are committed to providing compassionate, personalized outpatient infusion care in a welcoming and comfortable environment. Our experienced clinical teams work to help patients feel informed, supported, and confident throughout their treatment journeys. Supporting organizations like the Crohn’s & Colitis Foundation reflects our dedication to improving healthcare accessibility, raising awareness about chronic inflammatory conditions, and strengthening the communities we serve.
We extend our congratulations to the Crohn’s & Colitis Foundation on another successful Broadway’s Got Guts! Gala and an incredible fundraising achievement. We are grateful for the opportunity to support an organization that continues to make meaningful strides in IBD research, patient education, and advocacy. We remain committed to supporting patients and their families through accessible, high-quality infusion care and partnerships that help move healthcare forward. Together, we can continue raising awareness, supporting patients, and working toward a future free from Crohn’s disease and ulcerative colitis.

